Vision

Our vision is to offer hope and transform the lives of people with incurable cancers.

Mission

Our mission is to pioneer next-generation targeted radiotherapeutics through innovative vector agnostic alpha-particle platforms to help cancer patients live longer and healthier lives.

AIGA exists to deliver breakthrough targeted radiotherapeutics to help cancer patients live longer and healthier lives. It is focused on discovering and developing RadioLigand Therapies (RLT) employing an alpha particle theranostic platform to deliver life-changing innovations in challenging cancers. Theranostics is a rapidly growing commercial segment in oncology that enables enhanced cancer care and provides hope to patients worldwide.